Chia-Chang Wu

View Scopus Profile

Emailcharleswjjyahoo.comtw

h-index

Research activity per year

Education

2005-2013 Ph.D., School of Public Health, Taipei Medical University
1991-1997 M.D., School of Medicine, College of Medicine, Taipei Medical College

Experience

2025.08-2026.05 Director, Department of Medical Administration, Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare
2023.08- Professor, Department of Urology, School of Medicine, Collee of Medicine, Taipei Medical University
2022.01-2026.07 Vice Director, Research Center of Urology and Kidney, Taipei Medical University
Attending Physician, Department of Urology, Taipei Medical University Shuang Ho Hospital
Director, Department of Urology, Taipei Medical University Shuang Ho Hospital
2020.02-2023.08 Associate Professor, Department of Urology, School of Medicine, Collee of Medicine, Taipei Medical University
2017.02-2023.02 Director, Department of Urology, School of Medicine, College of Medicine, Taipei Medical University
2014.05-2020.01 Assistant Professor, Department of Urology, School of Medicine, Collee of Medicine, Taipei Medical University
2009.02-2014.05 Instructor, Department of Urology, School of Medicine, Taipei Medical University
2005.07-2008.06 Attending Physician, Taipei Tzu Chi Hospital
200.006-2005.07 Resident Physician/Attending Physician, En Chu Kong Hospital
Chief Resident, Urology, Taipei Medical University Hospital
Number 1 in 2009 Accreditation of specialist physicians of Urology
Investigator, Urology, Taipei Medical University-Shuang Ho Hospital
Member, Taiwan Society of Ultrasound in Medicine
Member, Taiwan Urological Association
Member, the Taiwanese Association of Andrology

Research Interests

Laparoscopic urinary tract tumor surgery
Laparoscopic Lichtenstein and laparoscopic varicocelectomy
Endoscopic urinary lithotomy
Male infertility and sterilization
General urinary system diseases

Fingerprint

Dive into the research topics where Chia-Chang Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

6 Finished

The Role of P2ry11-Mediated Macropinocytosis in Hormone Resistance and Targetability in Prostate Cancer Minimal Residual Disease
Wu, C.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
Prediction of Therapy Response and Susceptibility to Disease Relapse in Patients with Prostate Cancer: an Algorithm-Based Proteotranscriptomics Approach for Patient Stratification( III )
Wu, C.-C. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
Combinatorial Platelet-Rich Fibrin and Porous Biodegradable Mg-Based Bulk Metallic Glass as a Self-Locking Biological Scaffold for Critical-Size Bone Defect Repair
Wu, C.-C. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
Exploiting the Role of Acsl1/Fasn Signaling in Lipid Metabolic Reprogramming as a Novel Therapeutic Strategy for Patients with Chemo-/Immuno-Therapy-Resistant and Metastatic Urothelial Carcinoma
Wu, C.-C. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
Association of Arsenic Exposure、Cigarette Smoking、Micrornas Expression and Urothelial Carcinoma
Wu, C.-C. (PI)
9/1/15 → 8/31/16
Project: A - Government Institution › b - National Science and Technology Council

90 Article
2 Letter
1 Conference contribution
1 Comment/debate
More
- 1 Review article

Factors Affecting Oncological Outcomes in Upper Tract Urothelial Carcinoma Patients with Chronic Kidney Disease and End-Stage Renal Disease
Li, H. K., Lee, H. Y., Yeh, H. C., Huang, C. Y., Chen, C. H., Chang, C. H., Yeh, C. C., Weng, H. Y., Tai, T. Y., Tsai, Y. C., Wu, S. Y., Jiang, Y. H., Lee, Y. K., Chen, I. H. A., Lin, J. T., Hsueh, T. Y., Chiang, B. J., Chen, Y. T., Tseng, J. S. & Wu, C. C. & 3 others, Tai, T. E., Lin, W. Y. & Chung, S. D., Mar 2026, In: Biomedicines. 14, 3, 554.
Research output: Contribution to journal › Article › peer-review

Open Access
Overweight status predicts improved overall survival after radical nephroureterectomy for upper tract urothelial carcinoma
Wu, S. Y., Li, C. C., Wu, W. J., Huang, K. H., Liu, C. L., Wang, S. S., Li, J. R., Weng, H. Y., Tai, T. Y., Chen, P. C., Cheong, I. S., Tsai, C. Y., Cheng, P. Y., Hong, J. H., Chen, C. H., Tseng, J. S., Lin, W. R., Jiang, Y. H., Lee, Y. K. & Lin, P. H. & 11 others, Pang, S. T., Chen, Y. T., Chen, W. C., Wu, C. C., Hsueh, T. Y., Huang, H. C., Lin, W. Y., Yu, C. C., Fang, J. K., Yu, C. C. & Tsai, Y. C., Jan 2026, In: Canadian Journal of Urology. 33, 2, p. 325-337 13 p.
Research output: Contribution to journal › Article › peer-review
Correction: MED10 drives the oncogenicity and refractory phenotype of bladder urothelial carcinoma through the upregulation of hsa-miR-590 (Frontiers in Oncology, (2022), 11, (744937), 10.3389/fonc.2021.744937)
Wu, C. C., Wang, Y. H., Hu, S. W., Wu, W. L., Yeh, C. T. & Bamodu, O. A., 2025, In: Frontiers in Oncology. 15, 1667245.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Cytoreductive nephroureterectomy for treatment of upper urinary tract urothelial carcinoma initially diagnosed as node-positive
Wu, S. Y., Huang, C. P., Chang, C. H., Huang, S. K., Tseng, W. H., Li, W. M., Ke, H. L., Chen, I. H. A., Lin, J. T., Tseng, J. S., Lin, W. R., Jiang, Y. H., Lee, Y. K., Wang, S. S., Li, J. R., Chen, W. C., Tai, T. E., Lin, P. H., Hsueh, T. Y. & Li, H. K. & 9 others, Chen, P. C., Huang, C. Y., Chen, Y. T., Wu, C. C., Huang, H. C., Lin, W. Y., Weng, H. Y., Lo, C. W. & Tsai, Y. C., Dec 2025, In: Scientific Reports. 15, 1, 29481.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Link opens in a new tab Citation (Scopus)
Development and validation of a prediction model for early recurrence in upper tract urothelial carcinoma treated with radical nephroureterectomy
Chou, Y. J., Luo, H. L., Wang, H. J., Huang, S. K., Hsieh, Y. C., Wu, W. J., Li, C. C., Weng, H. Y., Tai, T. Y., Chang, C. H., Wu, H. C., Lin, P. H., Pang, J. S. T., Chen, C. H., Hong, J. H., Tseng, J. S., Chen, M., Chen, I. H. A., Yu, C. C. & Chen, P. C. & 22 others, Cheong, I. S., Tsai, C. Y., Cheng, P. Y., Jiang, Y. H., Lee, Y. K., Wang, S. S., Chen, C. S., Hsueh, T. Y., Chen, W. C., Wu, C. C., Chen, Y. T., Lin, W. Y., Wu, R. C. Y., Lo, C. W., Moschini, M., Soria, F., Laukhtina, E., Fazekas, T., Chlosta, M., Teoh, J. Y. C., Shariat, S. F. & Tsai, Y. C., Dec 2025, In: BMC Cancer. 25, 1, 808.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Link opens in a new tab Citations (Scopus)

Data for: Enhanced uropathogenic Escherichia coli-induced infection in uroepithelial cells by sugar through TLR-4 and JAK/STAT1 signaling pathways
Ho, C.-H. (Contributor), Fan, C.-K. (Contributor), Wu, C.-C. (Contributor), Yu, H.-J. (Contributor), Liu, H.-T. (Contributor), Chen, K.-C. (Contributor), Liu, S.-P. (Contributor) & Cheng, P.-C. (Creator), Mendeley Data, 2019
DOI: 10.17632/n25dwn3zjj.1, https://data.mendeley.com/datasets/n25dwn3zjj
Dataset

Chia-Chang Wu

Personal profile

Education

Experience

Research Interests

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

The Role of P2ry11-Mediated Macropinocytosis in Hormone Resistance and Targetability in Prostate Cancer Minimal Residual Disease

Prediction of Therapy Response and Susceptibility to Disease Relapse in Patients with Prostate Cancer: an Algorithm-Based Proteotranscriptomics Approach for Patient Stratification( III )

Combinatorial Platelet-Rich Fibrin and Porous Biodegradable Mg-Based Bulk Metallic Glass as a Self-Locking Biological Scaffold for Critical-Size Bone Defect Repair

Exploiting the Role of Acsl1/Fasn Signaling in Lipid Metabolic Reprogramming as a Novel Therapeutic Strategy for Patients with Chemo-/Immuno-Therapy-Resistant and Metastatic Urothelial Carcinoma

Association of Arsenic Exposure、Cigarette Smoking、Micrornas Expression and Urothelial Carcinoma

Factors Affecting Oncological Outcomes in Upper Tract Urothelial Carcinoma Patients with Chronic Kidney Disease and End-Stage Renal Disease

Overweight status predicts improved overall survival after radical nephroureterectomy for upper tract urothelial carcinoma

Correction: MED10 drives the oncogenicity and refractory phenotype of bladder urothelial carcinoma through the upregulation of hsa-miR-590 (Frontiers in Oncology, (2022), 11, (744937), 10.3389/fonc.2021.744937)

Cytoreductive nephroureterectomy for treatment of upper urinary tract urothelial carcinoma initially diagnosed as node-positive

Development and validation of a prediction model for early recurrence in upper tract urothelial carcinoma treated with radical nephroureterectomy

Data for: Enhanced uropathogenic Escherichia coli-induced infection in uroepithelial cells by sugar through TLR-4 and JAK/STAT1 signaling pathways

Chia-Chang Wu

Personal profile

Education

Experience

Research Interests

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output

Datasets